Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06620627
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-23
Brief Title:
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection PROCEED-CRC
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PROCEED-CRC
Brief Summary:
The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer CRC Samples will be used for research use and the development of a blood-based CRC screening test
Detailed Description:
Participants who meet study inclusion criteria will be invited to enroll in the study and will provide written consent prior to study procedures Participants will provide blood samples and will be required to have a colonoscopy performed within 120 days of their blood draw No test results from the blood collection will be provided to participants or clinicians
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None